Novavax COVID-19, Adjuvanted Vaccine: Overview and Safety

Information

Manufacturer: Novavax, Inc.

Dose quantity: 2 doses to complete the main schedule, with an interval of 3 to 8 weeks between doses.

People who are moderately or severely immunocompromised should also receive 2 doses, given 3 weeks apart (a 3rd primary dose is not currently authorized).

Booster Shot: Novavax COVID-19 vaccine is not authorized for use as a booster dose.

Type of Vaccine: Protein subunit

Administration mode: injection into the muscle of the upper arm

It does not have: eggs, preservatives, latex, metals
See the full list of ingredients

Name: NVX-CoV2373

Summary of safety data

• COVID-19 vaccines have undergone—and continue to undergo—the most intensive safety monitoring in U.S. history. Side effects that happen within 7 days of getting vaccinated are common but are mostly mild and only last a few days. Some people have reactions that affect their ability to do daily activities.
• Side effects (such as fever, chills, tiredness, and headache) throughout the body were more common after receiving the second dose of the vaccine.
• severe allergic reactions vaccinations are rare but can occur. Cases of myocarditis and pericarditis have been reported in people who received Novavax COVID-19 vaccine.

Learn more about the vaccine safety monitoring after its use has been authorized or approved.

–